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Neuronal nAChRs are a diverse family of pentameric ion
channels with wide distribution throughout cells of the
nervous and immune systems. However, the role of specific
subtypes in normal and pathological states remains poorly
understood due to the lack of selective probes. Here, we
used a binding assay based on acetylcholine-binding pro-
tein (AChBP), a homolog of the nicotinic acetylcholine
ligand-binding domain, to discover a novel a-conotoxin
(a-TxIA) in the venom of Conus textile. a-TxIA bound
with high affinity to AChBPs from different species and
selectively targeted the a3b2 nAChR subtype. A co-crystal
structure of Ac-AChBP with the enhanced potency analog
TxIA(A10L), revealed a 201 backbone tilt compared to other
AChBP–conotoxin complexes. This reorientation was coor-
dinated by a key salt bridge formed between Arg5 (TxIA)
and Asp195 (Ac-AChBP). Mutagenesis studies, biochemical
assays and electrophysiological recordings directly corre-
lated the interactions observed in the co-crystal structure to
binding affinity at AChBP and different nAChR subtypes.
Together, these results establish a new pharmacophore for
the design of novel subtype-selective ligands with thera-
peutic potential in nAChR-related diseases.
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Introduction
Acetylcholine binding proteins (AChBPs) have been identi-
fied from different snails, including Lymnaea stagnalis (Smit
et al, 2001), Aplysia californica (Hansen et al, 2004; Celie
et al, 2005a) and Bulinus truncatus (Celie et al, 2005b).
AChBPs are homologous to the ligand-binding domains
(LBDs) of the nicotinic acetylcholine receptors (nAChRs)
and pharmacological characterization has demonstrated
that their properties most closely resemble those of the a7
nAChRs (Smit et al, 2001), which also function as homopen-
tamers. Crystallization and structure determination of
AChBPs (Hansen et al, 2005; Celie et al, 2005a, b) from
these different species has revealed a highly conserved archi-
tecture, despite the relatively low sequence identity between
different AChBPs. A similar level of sequence homology is
found with the LBDs of members of the ligand-gated ion
channel family, comprising the nAChRs, GABA-A/C recep-
tors, 5-HT3 and glycine receptors. AChBP has been co-crystal-
lized with prototype ligands that are known to bind to
nAChRs, thus establishing the structural determinants for
ligand recognition of agonists such as nicotine and carbamyl-
choline (Celie et al, 2004), and antagonists such as different
a-conotoxins (Celie et al, 2005a; Ulens et al, 2006) and long-
chain snake neurotoxins (Bourne et al, 2005), and partial
agonists such as lobeline (Hansen et al, 2005). Comparison of
these different crystal structures has revealed conformational
changes occurring upon ligand binding, and has allowed
predictions as to how these conformational changes may be
coupled to channel opening through the loops that form the
interface with the transmembrane domain in the nAChR.
The venoms from cone snails are a rich source of peptides
with high affinity for several voltage- and ligand-gated ion
channels, including nAChRs (Olivera et al, 1990). Recently,
we and others have solved crystal structures of Ac-AChBP in
complex with two different a-conotoxins, namely PnIA(A10L
D14K) (Celie et al, 2005a) and ImI (Hansen et al, 2005; Ulens
et al, 2006). These two conotoxins greatly differ in their
selectivity among AChBPs and comparison of the toxin–
receptor interface in both complexes provided structural in-
sight into the molecular determinants of ligand selectivity
(Ulens et al, 2006).
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In addition to being remarkable probes for structural
studies, a-conotoxins also have therapeutic potential (Lewis
and Garcia, 2003). For example, Vc1.1, the first a-conotoxin
being developed to treat neuropathic pain also caused an
accelerated recovery of injured neurons (Satkunanathan et al,
2005). Recently, Vc1.1 was shown to specifically target a9/a10
nAChRs, providing a rationale for its analgesic property
(Vincler et al, 2006). Determining the specific roles of the
multiple nAChR subtypes under physiological or pathological
conditions and the development of drugs to treat nAChR-
related disorders, such as Parkinson’s disease and nicotine
addiction, requires further subtype-selective ligands.
In this study, we used Ls-AChBP as a bait to discover the
novel a-conotoxin TxIA from Conus textile. Pharmacological
characterization shows that TxIA binds with very high affi-
nity to AChBPs from different species, as well as selectively to
certain subtypes of neuronal nAChRs. The co-crystal struc-
ture of Ac-AChBP with a more potent analog TxIA(A10L),
revealed that this a-conotoxin adopts a different binding
orientation to that observed for other a-conotoxin–AChBP
complexes. A salt bridge between Arg5 in TxIA(A10L) and
Asp195 of Ac-AChBP was visible in the structure and the
importance of this interaction for AChBP binding and nAChR
selectivity was established using binding assays, surface
plasmon resonance (SPR) and electrophysiological experi-
ments with mutant receptors and conotoxin analogs. These
results highlight the potential of an AChBP screen to discover
novel ligands acting at the nAChR and provide a new
pharmacophore for the design of ligands with improved
subtype selectivity.
Results
Identification and pharmacological characterization of
a-conotoxin TxIA
We tested the activity of crude venoms obtained from more
than 30 species of Australian cone snails against Ls-AChBP in
a competitive binding assay with radiolabeled a-bungaro-
toxin (125I-Bgt). We chose the venom of cone snails as our
‘combinatorial library of ligands’, as all species tested so far
were shown to contain at least one nAChR ligand among the
50–200 unique conopeptides known to occur in each venom
(McIntosh et al, 1999). Accordingly, the venoms from all
species showed some competition in our Ls-AChBP-binding
assay (Figure 1A). We focused on C. textile venom, as full
competition with 125I-Bgt was observed, indicating the pre-
sence of a high affinity or abundant ligand (Figure 1A). Upon
isolation the active compound was found to be in low
abundance, indicating that it was relatively potent
(Figure 1B). Mass spectrometry revealed a monoisotopic
mass of 1656.68 Da, similar in size to previously isolated a-
conotoxins. N-terminal sequencing revealed a novel 16
amino-acid peptide belonging to the 4/7 a-conotoxin family,
which we named a-conotoxin TxIA (Table I). The calculated
mass (1661.67 Da) was consistent with two disulfide bonds
(–4 Da) and an amidated C terminus (–1 Da), two post-
translational modifications common in this class of conotox-
ins (Loughnan and Alewood, 2004).
Synthetic analogs of TxIA were assembled using Boc
chemistry for further analysis and to determine the cysteine
connectivity. The ‘native’ conformation (connectivity 1–3,
Figure 1 Isolation and characterization of a-conotoxin TxIA. (A) Ls-AChBP screening for a-conotoxins in venoms of 30 species of Australian
cone snails. (B) LC-MS profile of the crude venom of C. textile. TxIA was isolated as a minor component shown in the extracted ions for this
peptide. Inset shows a shell of C. textile. (C) Saturation binding experiments revealed a competitive interaction of TxIA with Ls-AChBP. When
an BIC50 concentration of TxIA was added, the Kd of
125I-Bgt shifted from 3.5 to 40 nM, whereas the Bmax remained unaffected.
(D) Displacement of 125I-Bgt from Ls-AChBP by a-conotoxins TxIA, PnIA and analogs (plot with all fixed to 100% in curve fit). Data in
(A), (C) and (D) represent the mean7s.e.m. of duplicate data obtained in three separate experiments.
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2–4) and the ‘ribbon’ fold (connectivity 1–4, 2–3) were both
able to displace 125I-Bgt bound to Ls-AChBP. However,
whereas the native fold displayed a Ki of 1.7 nM, the ribbon
fold was 380-fold less potent (Supplementary Figure 1).
Therefore, the connectivity is assumed to be 1–3, 2–4 in the
venom-isolated a-TxIA, as was found in all other a-conotox-
ins identified to date. Comparison with other synthetic
a-conotoxins known to bind nAChRs revealed that a-TxIA is
50-fold more potent than the a7 nAChR-selective PnIA(A10L)
in displacing 125I-Bgt at Ls-AChBP (Table I). The muscle
nAChR-selective EI displayed an intermediate Ki value of
496 nM, followed in decreasing order of potency by the a3b2
nAChR-selective PnIA (1.0 mM) and the a6/a3b2 nAChR-selec-
tive MII (1.1 mM), whereas EpI had the lowest affinity (7 mM).
Previously, pH was shown to influence the potency of the
histidine-containing a-MII in functional assays (Everhart
et al, 2004). This effect also applies to MII binding to Ls-
AChBP (Spearman’s test, Po0.01), whereas the other toxins
were most active at physiological pH (Supplementary Figure 2).
In a saturation-binding experiment, addition of an BIC50
concentration of native a-TxIA increased the Kd of
125I-Bgt
from 3.5 to 40 nM without affecting the maximum binding
Bmax, indicative of a competitive binding interaction
(Figure 1C). a-TxIA was also tested on rat brain membranes
using 125I-Bgt and 3H-epibatidine as tracers to determine the
affinity for a7 and mostly a4b2 neuronal nAChRs, respectively.
a-TxIA displaced 125I-Bgt with a Ki of 1.2 mM (a7 nAChR), but
failed to displace 3H-epibatidine using up to 10mM of peptide.
Finally, a-TxIA was tested in a functional assay on hetero-
logously expressed mammalian nAChRs (Figure 2). a-TxIA
potently inhibited nicotine-induced current at the a3b2
nAChR (IC50¼ 3.5 nM) and a7 nAChRs (IC50¼ 392 nM), but
had no activity at the a4b2 nAChR and muscle nAChR at
concentrations up to 10 mM. Thus, a-TxIA is among the most
a3b2-selective toxins identified.
Structure activity relationships
The sequence of a-TxIA was compared to previously identi-
fied 4/7 a-conotoxins (Table I). Interestingly, only three
residues are different from a-conotoxin PnIA, yet PnIA is
600-fold less potent than TxIA at Ls-AChBP. To identify which
of these residues conferred the high affinity at Ls-AChBP, we
synthesized PnIA and TxIA mutants covering two of the three
differences (Figure 1D and Table II). A third difference at
position 15 was not investigated, as it was located outside the
binding site identified in the co-crystal structure of Ac-AChBP
with PnIA(A10L D14K) (Celie et al, 2005a). For the mutants
tested, PnIA(A10L) had 12.5-fold higher affinity at Ls-AChBP,
20-fold higher affinity at the a7 nAChR, but 10-fold reduced
affinity at the a3b2 nAChR (Hogg et al, 1999; Luo et al, 1999;
Dutertre et al, 2005) (Table II). In contrast, TxIA(A10L) had
similar potency to native TxIA at Ls-AChBP (Figure 1D and
Table II), suggesting that Ile9 (Ala in PnIA) is able to
substitute for Leu10 in PnIA(A10L) in the conserved hydro-
phobic patch that we have shown previously interacts with
the complementary binding site of the nAChR (Dutertre et al,
2005). Despite the lack of effect on Ls-AChBP affinity,
TxIA(A10L) was 12- and 2-fold more potent at the a7 and
a3b2 nAChRs, respectively (Figure 2). Thus, a long-chain
hydrophobic residue (Leu or Ile) at position 9 or 10 is
important for high-affinity binding of TxIA and PnIA to Ls-
AChBP and the a7 nAChRs, but not a3b2 nAChRs. A second
difference is a Leu in position 5 of PnIA compared with an
Arg in TxIA. As this position is well placed to directly interact
with the receptor (Dutertre et al, 2005), this change in the
physical property and length of the side chain could be an
important contributor to high-affinity binding to Ls-AChBP. In
support of this hypothesis, EI also has high affinity for Ls-
AChBP and a positive charge in the equivalent position,
whereas the low affinity [Y15]-EpI has a negatively charged
Table I Binding affinities (nM) of a-conotoxins for Ls-AChBP
a-Conotoxin Sequence Target Ki (CI) Hill slope
TxIA GCCSRPPCIANNPDLC AChBP4a3b24a7 1.7 (1.1–2.8) 0.79
PnIA(A10L) GCCSLPPCALNNPDYC a74a3b2 80 (44–148) 1.04
EI RDOGCCYHPTCNMSNPQIC muscle 496 (430–572) 0.70
PnIA GCCSLPPCAANNPDYC a3b24a7 1000 (768–1303) 0.93
MII GCCSNPVCHLEHSNLC a3a6b2 1093 (861–1388) 0.84
[Y15]-EpI GCCSDPRCNMNNPDYC a3b2/b4 6976 (5704–8532) 0.87
Bold indicate conserved residues.
Figure 2 Antagonist activity of a-conotoxin TxIA and analogs at
oocyte-expressed rat a3b2 (A) and a7 (B) nAChRs. Oocytes were
clamped at 70 mV and 100 mM ACh (a3b2) or nicotine (a7) were
applied for 2 s in 4 min intervals. Toxins were applied for 3 min.
Data are represented as the mean7s.e.m. of at least four oocytes.
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aspartic acid at this position. In agreement with these ob-
servations, PnIA(L5R A10L) had 220-fold increased affinity
for Ls-AChBP compared to PnIA, clearly demonstrating the
important role of Arg5 for high-affinity binding to Ls-AChBP
(Figure 1D and Table II). The role of this residue appears also
important for a3b2 nAChR binding (10-fold increased affinity
of PnIA(L5R A10L) compared to PnIA(A10L) at a3b2 nAChR),
but not for the a7 nAChR (same affinity compared to
PnIA(A10L)), suggesting that Arg5 interacts with Ls-AChBP
and a3b2 nAChRs in a similar manner (Figure 2 and Table II).
Crystal structure of Ac-AChBP in complex with
TxIA(A10L)
To gain further insight into the nature of the interactions of a-
TxIA with AChBP and their contribution to high affinity
binding, we solved the crystal structure of Ac-AChBP in
complex with the most potent TxIA analog, TxIA(A10L).
Co-crystals were initially obtained with Ls-AChBP, Bt-
AChBP and Ac-AChBP, but the latter gave diffraction data of
better quality (see Supplementary Table I for statistics).
TxIA(A10L) has comparable affinities to displace 3H-epibati-
dine from Lymnaea and Aplysia AChBPs (data not shown).
The structure of the complex was determined at 2.4 A˚ resolu-
tion (Figure 3A) and solved by molecular replacement. The
asymmetric unit contains two pentamers and all binding sites
were occupied by TxIA(A10L). The structure of Ac-AChBP in
complex with TxIA(A10L) is very similar to other a-conotoxin
complexes, with r.m.s.d. of 0.73 A˚ (1023 Ca atoms) upon
superposition with the complex of Ac-AChBP with PnIA(A10L
D14K) (Celie et al, 2005a) and 0.67 A˚ (1024 Ca atoms) for the
Ac-AChBP complex with ImI (Ulens et al, 2006). The r.m.s.d.
between monomers in the Ac-AChBP–TxIA(A10L) complex is
0.3470.04 A˚. TxIA(A10L) binds with loop C displaced out-
ward by a distance of 10.8770.50 A˚ as measured between the
Table II Potency (nM) of a-conotoxins TxIA, PnIA and analogues at AChBP and rat nAChRs
125I-Bgt binding Electrophysiology
a-Conotoxin Sequence Ls-AChBP, Ki (CI) a7nAChR, IC50 (CI) a3b2 nAChR, IC50 (CI)
TxIA(A10L) GCCSRPPCILNNPDLC 1.1 (0.8–1.6) 39 (31–49) 2.0 (1.8–2.4)
TxIA GCCSRPPCIANNPDLC 1.7 (1.1–2.8) 392 (310–490) 3.6 (2.9–4.4)
PnIA(L5R-A10L) GCCSRPPCALNNPDYC 6.2 (4.4–8.7) 10 (8.3–13) 4.6 (3.7–5.8)
PnIA(A10L) GCCSLPPCALNNPDYC 80 (44–150) 13a 99a/55b
PnIA GCCSLPPCAANNPDYC 1000 (770–1300) 252a 10a/8b
Residue bolded to indicate differences between PnIA and TxIA. Hill slope values were not significantly different from –1 (95% CI), except TxIA
at AChBP (–0.93/–0.67), TxIA(A10L) at a3b2 (–1.48/–1.04), and PnIA(L5R, A10L) at a7 (–0.94/–0.67) and a3b2 (–0.90/–0.62). Data from
aLuo
et al (1999) and bDutertre et al (2005).
Figure 3 (A) Crystal structure of Ac-AChBP in complex with TxIA(A10L). The model is shown along the five-fold symmetry axis. a-Conotoxins
are shown in red. (B) Superposition of the subunit interface from Ac-AChBP in complex with TxIA(A10L) and PnIA(A10L D14K). The principal
face of the binding site is shown in shades of yellow, the complementary face in shades of blue. The superposition illustrates the different
orientation of the conotoxin backbone in the binding pocket. PnIA(A10L D14K) is shown in blue, TxIA(A10L) in red. (C) Comparison of the
different backbone orientations observed in co-crystal structures of Ac-AChBP with different a-conotoxins. TxIA(A10L), shown in red, is tilted
by a 201 rotation around Pro7 with respect to PnIA(A10L D14K), shown in blue. The backbone orientation of a-conotoxin ImI, shown in
magenta, is very similar to PnIA(A10L D14K) even though it is much shorter and forms a different network of interactions. Lines represent
disulfide bridges. Detailed view of the molecular interactions that results in the different backbone orientations of (D) TxIA, (E) PhIA(A10L
D14K) and (F) ImI within the binding site. The principal face of the binding site is shown in yellow, the complementary face in blue. The
conotoxins are colored according to the color scheme in (C). Dashed lines represent hydrogen bonds or electrostatic interactions.
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Cys188 Ca atom in the Ac-AChBP complex with TxIA(A10L)
and the HEPES-bound Ac-AChBP structure (Celie et al,
2005a), similar to values measured for other a-conotoxin
complexes. We previously observedB31 rigid body rotations
of the monomers in the Ac-AChBP complex with PnIA(A10L
D14K) (Celie et al, 2005a), whereas these rotations were not
seen in the Ac-AChBP complex with ImI (Ulens et al, 2006).
The Ac-AChBP complex with TxIA(A10L) displays intermedi-
ate rotations (1–21) of the monomers with respect to each
other, which are most likely due to crystal contacts. The
structure of TxIA(A10L) itself is very similar to other a-
conotoxins and has an r.m.s.d. of 0.6470.10 A˚ upon super-
position with PnIA (PDB accession code 1PEN). TxIA(A10L)
covers a surface area in the binding pocket of 788718 A˚2,
which is intermediate between the receptor–toxin interfaces
formed with PnIA(A10L D14K) (827732 A˚2) and ImI
(679715 A˚2) (Ulens et al, 2006).
We previously observed that PnIA(A10L D14K) and ImI
share a similar orientation in the binding pocket, but differ
dramatically in the nature of interactions formed within the
binding site (Celie et al, 2005a; Ulens et al, 2006).
Surprisingly, we see that TxIA(A10L) adopts an orientation
that is different from those seen in other a-conotoxin–AChBP
complexes. TxIA(A10L) is tilted 201 downward by a pivotal
reorientation of the conotoxin around Pro7 (Figure 3B),
which results in displacement by a distance of
4.7270.83 A˚, as measured between the Ca atoms at position
14 in the TxIA(A10L) and PnIA(A10L D14K) complexes. This
different orientation of the conotoxin compared to those seen
in other complexes (Figure 3C) is sustained by Arg5, which
projects deep onto the principal face of the binding site and
forms a hydrogen bond with Tyr186 and a salt bridge with
Asp195 (Figure 3D), an interaction not seen in any of the
other a-conotoxin complexes (Figure 3E and F). The structur-
al data thus confirm a key role of Arg5 in the high-affinity
binding of TxIA(A10L) to Ac-AChBP. The interface of
TxIA(A10L) with the principal binding site is further char-
acterized by the formation of four additional hydrogen bonds
between TxIA and Pro7-Trp145 (loop B), TxIA and Asn12-
Glu191 (loop C), and TxIA Pro7 and Asn11-Tyr193 (loop C)
(Figure 3D). TxIA Pro7 also seems to play a dominant role in
forming extensive van der Waals interactions with residues of
the principal face that are not involved in contacts with
PnIA(A10L D14K), namely Tyr91 (loop A), and Ser144,
Trp145, Val146 and Tyr147 (loop B). In contrast, interaction
of TxIA(A10L) with residues of the complementary face are
similar to those seen in the Ac-AChBP complex with
PnIA(A10L D14K) and are mostly hydrophobic in nature.
Comparison of the different AChBP–conotoxin complexes
reinforces the notion that a-conotoxins can use different
surface contacts to interact with the principal binding site
(Figure 4A), whereas the surface area that contacts the
complementary face of the binding site remains relatively
conserved (Figure 4B). The calculated surface area of con-
otoxin ImI (1221713 A˚2), for example, is smaller than
PnIA(A10L D14K) (1508717 A˚2) and TxIA(A10L)
(1488729 A˚2), but they all share a hydrophobic patch on
one face of their surface that projects on the complementary
binding site. On the other hand, ImI has two arginine residues
(Arg7 and Arg11) that protrude into the principal binding site,
a surface property not present in PnIA(A10L D14K).
TxIA(A10L) seems to have surface properties that are inter-
mediate between ImI and PnIA(A10L D14K), even though
TxIA and PnIA are the same length and TxIA has the
relatively exposed Arg5.
Functional importance of an electrostatic interaction
for high affinity binding of a-conotoxins to AChBPs
and a3b2 nAChRs
Structure–activity relationships between TxIA analogs indi-
cated an important role for Arg5 in the high-affinity binding
of TxIA to AChBPs. Indeed, incorporation of an Arg residue in
PnIA(A10L) at the equivalent position enhanced the affinity
for Ls-AChBP that approached TxIA(A10L) affinity, with the
tight electrostatic interaction between Arg5 of TxIA(A10L)
and Asp195 of Ac-AChBP seen in our co-crystal structure
Figure 4 Surface representation of the three a-conotoxins that have been co-crystallized with Ac-AChBP. The surface of the a-conotoxin facing
the principal binding site is shown in (A), the complementary binding site in (B). Ac-AChBP is shown in a transparent view for clarity. The
principal subunit (þ ) of Ac-AChBP is shown in yellow, the complementary subunit () in blue.
Correlation of binding orientations and nAChR subtype selectivity
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explaining this effect. To further confirm this interaction, we
mutated Asp195 in Ac-AChBP to Ala, Asn and Lys (unfortu-
nately, insufficient Ac-AChBP D195K was expressed to allow
a complete pharmacological characterization). In a competi-
tion assay, D195A and D195N showed binding properties for
nicotine and acetylcholine that are comparable to wt Ac-
AChBP (Ki nicotine¼ 0.6870.10 mM and 0.8170.13 mM for
D195A and D195N, respectively). However, TxIA and
TxIA(A10L) showed a 30- to 50-fold reduction in affinity for
the D195A and D195N mutants (Figure 5A). A similar reduc-
tion was also observed for PnIA(L5R A10L). In contrast, the
affinity of PnIA(A10L D14K), which lacks an Arg at position
5, for D195A and D195N remained virtually unchanged. In
addition, we compared the kinetic behavior of TxIA analogs
on Ac-AChBP and the D195A mutant using SPR. In agreement
with results from the binding assay, we observe an approxi-
mately sixfold acceleration in the dissociation rate for Arg5-
containing a-conotoxins TxIA, TxIA(A10L) and PnIA(L5R
A10L), whereas the dissociation kinetics for PnIA(A10L
D14K) were unaffected by the D195A mutation (Figure 5B).
These results provide strong evidence that the observed drop
in affinity for Arg5-containing analogs at D195A can be
directly attributed to the loss of an energetically favorable
interaction with Asp195, which stabilizes Arg5-containing
a-conotoxins in their bound position.
To extrapolate the functional importance of this electro-
static interaction to mammalian nAChRs, we introduced the
equivalent D197A and D195A mutations in a3b2 and a7
nAChRs, respectively, and compared the potency of TxIA
analogs by two-electrode voltage clamp analysis on the
oocyte expressed mutant receptors (Figure 5C). In agreement
with the results obtained with the Ac-AChBP mutants, we see
that Arg5-containing conotoxins had 200- to 500-fold de-
creased activity at D197A-a3b2. Together, these results show
that the electrostatic interaction between Arg5 of TxIA(A10L)
and Asp195 in Ac-AChBP and Asp197 in a3b2 nAChRs pro-
vides an important energetic contribution to their enhanced
affinity at these receptors. In contrast, the activities of TxIA,
TxIA(A10L) and PnIA(L5R A10L) at D195A-a7 were little
affected, suggesting that other interactions, probably invol-
ving a the hydrophobic patch around position 9/10, dominate
a-conotoxin interactions with this subtype.
Comparison between nAChR subtypes
It was an intriguing finding that D195A and D197A mutations
had a dramatic effect on TxIA binding at AChBP and a3b2
nAChR, respectively, whereas the corresponding mutation
(D195A) in a7 nAChR barely affected the binding of Arg5-
containing conotoxins including TxIA. To help understand
this difference, we constructed homology models of both
nAChRs and docked TxIA(A10L) into its binding site.
Analysis of conotoxin binding in the a3b2 receptor clearly
shows that TxIA(A10L) adopts a backbone orientation that is
similar to the binding mode observed in our Ac-AChBP co-
crystal structure (Figure 5D). This interaction specifically
allows an electrostatic interaction between Arg5 and the
conserved Asp residue D197, in agreement with our experi-
mental results. To further confirm the existence of this novel
binding mode in native a3b2 nAChRs, we utilized a b2-subunit
mutant possessing enhanced hydrophobic contacts between
the toxin and receptor (Dutertre et al, 2005). As expected,
PnIA(L5R A10L) binds to a3-[V109A]b2 with an affinity over
10 times higher (0.34 nM, CI 0.30–0.38) than observed at the
wild-type receptor (4.6 nM, CI 3.69–5.83) (see Supplementary
Figure 4). Interestingly, when this b2-subunit mutant is
coexpressed with the low affinity [D197A]a3 (2300 nM, CI
Figure 5 Functional contribution of the electrostatic interaction between Arg5-TxIA and an Asp residue of the principal binding subunit of Ac-
AChBP and different nAChR subtypes. (A) Ki estimates from binding assays on wild-type Ac-AChBP, D195A and D195N mutants demonstrating
the loss of affinity for Arg5-containing conotoxins. (B) Surface plasmon resonance experiments on wild-type Ac-AChBP (red traces) and D195A
mutant (blue traces) for TxIA analogs and PnIA(A10L D14K). (C) Effect of the Asp-mutations on the potency of TxIA and analogs to inhibit a7
and a3b2nAChR current. (D, E) Homology models for the interaction of TxIA(A10L) with a3b2 and a7 nAChRs. The a3b2 model also shows the
Arg–Asp interaction observed in the co-crystal structure.
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1780–2966), we observed a dramatic (4100-fold) rescue of
PnIA(L5R A10L) affinity (20.5 nM, CI 17.4–24.1). This rescue
effect can be explained if the C-terminal hydrophobic half of
toxin repositions to interact with [V109A]b2, as seen in the
Ac-AChBP–PnIA(A10L D14K) co-crystal structure (Celie
et al, 2005a) compensating for the loss of the energetically
favorable Arg5–D197 interaction. Due to conservation
in the binding pocket, docking of TxIA(A10L) in the a7
homology model gave a similar overall result to that
obtained using a a3b2 model. However, our experimental
results show that, for this subtype, Arg5 is unlikely to interact
with D195. TxIA(A10L) was therefore placed in the a7 bind-
ing pocket using the PnIA(A10L D14K) binding mode (Celie
et al, 2005a) (Figure 5E). This orientation of the conotoxin
does not allow a direct interaction between Arg5 and Asp195,
explaining the lack of effect the a7-D195A mutation. Instead,
hydrophobic interactions with the complementary side
(equivalent of the b-subunit) dominate the binding interac-
tion at a7.
Finally, mapping the a7 sequence to the AChBP crystal
structure reveals an additional positive charge, Lys184 posi-
tioned where it could form an internal salt bridge with
Asp195, thus reducing the likelihood of an interaction with
Arg5 of TxIA(A10L). In addition, the downward tilt of
TxIA(A10L) toward Asp195 might be prevented by a H-
bond expected between the TxIA-Leu10 main chain and
Gln115 in the a7 nAChR. Together, these observations support
the possibility that TxIA(A10L) binds to a7 in a conformation
observed for ImI and PnIA mutants in the AChBP subtypes. In
such a conformation, the relevance of an Arg5-Asp195 salt
bridge would be minimized, as has been observed for ImI
binding to AChBP. In contrast, the binding to the a3b2 nAChR
subtype is likely to be similar to that observed in our AChBP/
conotoxin complex, including an important contribution to
binding from the Arg5-Asp195 salt bridge.
Discussion
In this study, we demonstrate that an AChBP screen can be
used to discover and guide the isolation of new a-conotoxins
in crude venom. This rapid and sensitive assay has advan-
tages over fluorescent and electrophysiological methods used
previously, and is amenable to high-throughput applications.
As all a-conotoxins tested bound to Ls-AChBP in the micro-
molar to mid nanomolar range, despite having distinct
nAChR preferences for muscle and homomeric and hetero-
meric neuronal nAChR subtypes, it appears that Ls-AChBP
has retained ancestral nAChR features that allow a broad
range of nAChR ligands to bind. In support, an Ls-AChBP
screen of over 30 different cone snail venoms revealed that all
significantly displaced 125I-Bgt binding. This high hit-rate
supports the hypothesis that each cone snail venom contains
at least one nAChR antagonist (McIntosh et al, 1999). Given
that many cone snails are molluscivorous, and the apparent
broad distribution of AChBP in molluscs, AChBP could re-
present a previously unrecognized molecular target for a-
conotoxins with the potential to disrupt molluscan neuro-
transmission.
The sensitivity of an Ls-AChBP screen is demonstrated
with the isolation of a-TxIA, a trace component of C. textile
venom. The complete pharmacological characterization at
Ls-AChBP and nAChRs was subsequently achieved using an
identical synthetic form. a-TxIA was found to be the most
potent a-conotoxin acting at Ls-AChBP reported to date and
also had high affinity for certain mammalian nAChRs. Low
nanomolar concentrations of a-TxIA were sufficient to inhibit
a3b2 nAChR, whereas 100-fold higher concentrations were
needed to block a7 nAChR current. In contrast, a-OmIA,
which also displays high-affinity binding to AChBPs, is
equipotent at a3b2 and a7 nAChRs (Talley et al, 2006).
Sequence comparison of TxIA with other a-conotoxins and
synthesis of selected TxIA analogs revealed important con-
tributions from hydrophobic residues at position 9 and 10 and
the key role of Arg5 for high-affinity interactions at Ls-AChBP.
Indeed, substitution of Arg5 in PnIA(A10L) produced a gain-
of-function analog with similar properties to TxIA. The co-
crystal structure of Ac-AChBP in complex with the higher
potency analog TxIA(A10L), confirmed the crucial role of
Arg5, which is coordinated by Asp195 and Tyr186, an inter-
action not seen in two other Ac-AChBP–conotoxin complexes
(Hansen et al, 2005; Celie et al, 2005a; Ulens et al, 2006). The
presence of this salt bridge contributed to a 201 downward tilt
of the toxin backbone when compared to PnIA(A10L D14K).
An electrostatic interaction was also observed between Arg7
of conotoxin ImI and Asp195 in only one of the two available
Ac-AChBP co-crystal structures (PDB accession codes 2BYP
and 2C9T). However, mutant cycle analysis has shown that
the interaction between Arg7 and Asp197 in nAChRs does not
contribute to high-affinity binding of conotoxin ImI (Quiram
et al, 1999), most likely due to the different orientation of the
toxin in the binding site. By mutating Asp195 in the back-
ground of Ac-AChBP, we confirmed the functional impor-
tance of the electrostatic interaction between Arg5 and
Asp195 as observed in the co-crystal structure. Importantly,
we observed that the affinity of PnIA(A10L D14K) remains
unaffected by Asp195 mutations. This result provides strong
evidence that the enhanced affinity of Arg5-containing
conotoxins can be attributed to an energetically favorable
electrostatic interaction with Asp195 in Ac-AChBP. In
combination with electrophysiological recordings on mutant
nAChRs, we demonstrated that this conclusion extrapolates
to a3b2 nAChRs, but not to a7 nAChRs. As Asp195 is highly
conserved among AChBPs and nAChRs, Arg5 TxIA may share
a common set of binding interactions in AChBPs and certain
nAChR subtypes.
The reorientation of TxIA(A10L) in the binding pocket of
Ac-AChBP is a surprising observation in light of the two other
a-conotoxin complexes that we and others have previously
determined (Hansen et al, 2005; Celie et al, 2005a; Ulens et al,
2006). Such differences highlight that docking simulations
based on the backbone orientation of PnIA(A10L D14K)
(Talley et al, 2006) or contacts analysis based on superposi-
tion of the a-conotoxin backbone (Clark et al, 2006) should
be interpreted with caution, as these approaches may not
adequately address residue changes or the reorientation of
side chains in the toxin or receptor, which could generate
backbone reorientations as observed for TxIA(A10L).
However, from our analysis of homology models, it appears
likely that TxIA(A10L) adopts the same orientation in a3b2
nAChRs as seen in our crystal structure, whereas it may adopt
a PnIA-like binding orientation in the a7 nAChR binding
pocket. Given this result, it is somewhat surprising that
TxIA has no affinity for a4b2 nAChRs despite the presence
of an equivalent Asp residue and the close similarity to a3b2
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nAChRs across the principal binding face. As no obvious
clash could be identified during docking to an a4b2 homology
model, it appears that AChBP is not a strong predictor of a4b2
structure, perhaps reflecting different docking pathways or an
altered binding site structure.
In conclusion, we have demonstrated that Ls-AChBP can
be used to rapidly identify new ligands for nAChRs. By
screening the crude venom of different cone snails, we
discovered a new a-conotoxin TxIA with enhanced subtype
selectivity for a3b2 nAChRs. Co-crystallization of the most
potent analog TxIA(A10L) with Ac-AChBP identified a new
a-conotoxin binding mode that was stabilized by a critical salt
bridge between Arg5-TxIA(A10L) and a highly conserved Asp
residue on the principal face of the binding face of Ac-AChBP.
The functional importance of this interaction was confirmed
through mutagenesis studies in different nAChR subtypes and
AChBP. These results establish a structural framework for
developing ligands with enhanced selectivity for the a3b2
nAChR. Engineering AChBPs with the ligand-binding sites of
specific nAChR subtypes, or with the ligand-binding sites of
other ligand-gated ion channels, is expected to identify
specific pairwise interactions underlying nAChR selectivity
and further expand the potential of this protein scaffold to
discover novel pharmacological probes.
Materials and methods
TxIA Isolation, sequencing and mass spectrometry
Venom from C. textile specimens was extracted and fractionated
as described previously for other cone species (Lewis, 2000).
Biological activity was tested using the Ls-AChBP radioligand-
binding assay as described previously (Smit et al, 2001). This assay
directed the final purification of the active compound on analytical
RP-HPLC (C18 Phenomenex column). A 20 pmol portion of pure
peptide was Edman sequenced (Biomolecular Research Facility,
Newcastle, Australia) on an Procise HT (Applied Biosystem).
Molecular mass analysis of the native and synthetic peptides and
LC-MS analysis of crude C. textile venom were performed on a C18
Phenomenex column (2.1150 mm, 5 mm) eluted with 0 to 60% B
in 60 min (A¼ 0.05% TFA; B¼ 0.045% TFA, 90% ACN). Eluant was
monitored with a PE-Sciex API III triple quadrupole mass spectro-
meter (Thornhill, Ontario, Canada) over m/z 400–2000 and data
analyzed using Analyst software (Agilent, CA, USA).
Binding assays
Competitive binding assays with His-tagged Ls-AChBP and 125I-
radiolabeled a-bungarotoxin (specific radioactivity 5.5 TBq/mmol)
were carried out as described previously (Smit et al, 2001). A
binding assay was established using P2 rat brain homogenate as
described previously (Rapier et al, 1990), with a final protein
concentration of 6 mg/ml as determined by a BCA protein assay
(Pierce, Rockford, IL, USA). Various concentrations of conotoxins
diluted in 200 ml incubation buffer (50 mM HEPES at pH 7.4,
100 mM NaCl, 0.2% BSA) were incubated for 90 min in 100ml P2
membrane with a final concentration of 3 nM 125I-a-bungarotoxin to
measure binding to a7 nAChRs, or 1 nM
3H-epibatidine (Amersham
Biosciences, Castle Hill, Australia) plus 2 mM cold a-bungarotoxin
for non-a7 nAChRs.
Binding assays with untagged Ac-AChBP and D195 mutants were
performed using 5 nM 3H-epibatidine. Ligands were incubated in a
white Optiplate-96 (Perkin Elmer) with radioligand and protein (30–
120 ng) in binding buffer (PBS, 20 mM Tris at pH 8, 0.05% Tween
20) in a final volume of 100ml. FlashBlue GPCR beads (2 mg/ml)
(Perkin Elmer) were added and after 90 min incubation and 16 h
standing in the dark, the radioactivity was measured with a Wallac
1450 MicroBeta liquid scintillation counter. Binding-data were
evaluated by a nonlinear, least squares one-site competition curve
fitting procedure using Prism 4.01 (GraphPad Software Inc., San
Diego, CA, USA).
Protein expression, purification and peptide synthesis
Untagged Ac-AChBP was expressed from baculovirus in SF9 insect
cells and purified from medium as described previously (Celie et al,
2004). Ac-AChBP D195 mutants were constructed using a Quik-
Change approach (Stratagene, La Jolla, CA, USA) and verified using
DNA sequencing. All peptides were synthesized using Boc
chemistry with in situ neutralization protocols as described
previously (Schnolzer et al, 1992). The oxidized peptides were
purified by RP-HPLC and analyzed by electrospray mass spectro-
metry.
Electrophysiology
cDNAs encoding neuronal nAChRs were provided by J. Patrick
(Baylor College of Medicine, Houston, TX, USA) and subcloned into
the oocyte expression vector pNKS2 (Dutertre et al, 2005). Site-
directed mutagenesis was performed with the QuikChange muta-
genesis Kit (Stratagene, La Jolla, CA, USA) and primers were
synthesized by MWG Biotech AG (Ebersberg, Germany). Sequences
were verified by didesoxynucleotide sequencing (MWG Biotec AG).
cRNA was synthesized from linearized plasmids with SP6 RNA
polymerase using the mMessage mMachine kit (Ambion, Austin,
TX, USA). Xenopus laevis frogs were purchased from Nasco
International (Fort Atkinson, WI, USA). Oocytes were prepared as
described previously (Dutertre et al, 2005) and injected with 50 nl
aliquots of cRNA (0.5 mg/ml). Two-electrode voltage-clamp record-
ings were performed as described previously (Dutertre et al, 2005).
Current responses to acetylcholine or nicotine were measured 1–10
days after cRNA injection at a holding potential of 70 mV using a
Turbo Tec 05X Amplifier (NPI Electronic, Tamm, Germany) and Cell
Works software. Currents were filtered at 200 Hz and digitized at
400 Hz. The perfusion medium was automatically switched using a
custom-made magnetic valve system. A fast and reproducible
solution exchange (o300 ms) was achieved using a 50ml funnel-
shaped oocyte chamber combined with a fast solution flow
(B150ml/s) fed through a custom-made manifold mounted
immediately above the oocyte. Agonist pulses were applied for 2 s
at 4 min intervals. Peptides were applied for three minutes in a static
bath when responses to three consecutive agonist applications
differed by less than 10%. EC50 values were calculated from a
nonlinear fit of the Hill equation to the data (GraphPad version 3.0,
San Diego, CA, USA). Data are presented as mean7s.e. from at least
four experiments.
SPR spectroscopy
SPR spectroscopy was performed at 251C on a Biacore T100
(Uppsala, Sweden). Proteins were immobilized on a CM5 chip using
the amine coupling procedure where the proteins at 0.1 mg/ml
concentration were flown over the chip at 5 ml/min in 10 mM
sodium acetate at pH 4.0. Approximately 5000 response units (RUs)
of Ac-AChBP D195A and wild-type Ac-AChBP were immobilized on
the chip and the empty flow cell was used as the control.
Conotoxins (5–600 nM) in running buffer (25 mM sodium phos-
phate at pH 8.0, 100 mM sodium chloride) were injected across the
chip at 30ml/min. Biacore T100 evaluation software was used for
analysis of the experimental data. GraphPad Prism (GraphPad
version 4.0, San Diego, CA, USA) was used to generate final figures.
Crystallography
Crystals of Ac-AChBP in complex with TxIA(A10L) were grown in
nanoliter drops by mixing 200 nl protein solution with 200 nl
reservoir solution composed of 200 mM sodium malonate, 20%
polyethyleneglycol 3350 and bistrispropane at pH 8.5. The crystals
belong to spacegroup P1 and have the following unit cell
dimensions: a¼ 72.54 A˚, b¼ 85.75 A˚, c¼ 121.67 A˚, a¼ 90.141,
b¼ 80.011, g¼ 70.641. Glycerol was used as a cryoprotectant and
incrementally added to the mother liquor to a final concentration of
30% before flash-freezing the crystals by immersion in liquid
nitrogen. Diffraction data were collected at beamline X06SA at the
Swiss Light Source, Villigen. The resolution of observed reflections
rapidly decayed from 1.8 to 2.8 A˚ during a 1801 sweep due to
radiation sensitivity of the crystals. In addition, the diffraction data
showed signs of nonmerohedral twinning. The main crystal lattice
was indexed with MOSFLM and data reduction and scaling was
carried out with SCALA using the CCP4 program suite (CCP4,
1994). The protein structure was solved by molecular replacement
with PHASER (McCoy et al, 2005) and the open C-loop structure of
Ac-AChBP as the search model (PDB accession code 2C9T). The
Correlation of binding orientations and nAChR subtype selectivity
S Dutertre et al
&2007 European Molecular Biology Organization The EMBO Journal VOL 26 | NO 16 | 2007 3865
initial model was refined to Rwork¼ 27% and Rfree¼ 31% with
REFMAC (Murshudov et al, 1997) using NCS and TLS restraints
(Winn et al, 2001). Difference electron density maps clearly
indicated the occupancy of all binding sites by TxIA(A10L). The
a-conotoxins were built into density with COOT (Emsley and
Cowtan, 2004) using the structure of PnIA(A10L D14K) as a
template (PDB accession code 2BR8). The model of Ac-AChBP with
TxIA(A10L) bound was then further refined to Rwork¼ 24% and
Rfree¼ 30%. The issue of nonmerohedral twinning was addressed
by reprocessing the diffraction data with EVAL14 (Duisenberg et al,
2003) and deconvoluting overlapping reflections from the interfer-
ing lattice. The resulting electron density map was characterized by
a lower noise level, but higher R-values for the refined protein
model, which is expected due to lack of profile fitting in EVAL14
(Duisenberg et al, 2003). Further refinement of the structure was
therefore carried out using MOSFLM-processed data. Difference
electron density peaks near most of the disulfide bridges in Ac-
AChBP and TxIA(A10L) indicated severe radiation damage. There-
fore, diffraction data over a 3601 sweep were collected on multiple
segments of the crystal at beamline EH23-2 of the European
Synchrotron Radiation Facility, Grenoble. The beam was attenuated
to minimize radiation sensitivity and a merged data set with
improved statistics was obtained to 2.4 A˚ resolution including data
to I/sI¼ 1. The model was automatically rebuilt using pyWARP
(Cohen et al, 2004) and has a Rwork¼ 23% and Rfree¼ 25% with
good geometry after iterative cycles of manual rebuilding and
refinement. Structure validation was carried out using WHATIF
(Hooft et al, 1996) and MOLPROBITY (Davis et al, 2004). Full
molecular replacement and refinement of the data to 2.7 A˚, using a
more conservative data cut-off (I/sI¼ 2), showed that the electron
density did not change, but automatic rebuilding failed, indicating
that the weak data contained significant information and that any
errors in their measurement were sufficiently reduced by the use of
maximum likelyhood refinement. Coordinates have been deposited
in the Protein Data Bank with accession code 2UZ6. AREAIMOL and
CONTACT were used to analyze interaction surface areas and
contacts (CCP4, 1994). Interaction surface areas are reported as
average7s.d. of binding sites occupied by conotoxin and in the
context of the number of pentamers present in the asymmetric unit.
Interactions between residues of conotoxins and Ac-AChBP were
only considered if present in at least three of five binding sites.
Figures were prepared with PYMOL (DeLano Scientific, San Carlos,
CA, USA).
Molecular modeling
The crystal structure of TxIA(A10L) bound to Ac-AChBP was used
as a template to build homology models of rat a7, a3b2 and a4b2
nAChRs following the method described by Dutertre et al (2005).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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